Company intelligence / Profile preview

Vigenius Biotech

Villa Ballester, Buenos Aires, Argentinavigenius.com.ar ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Vigenius Biotech specializes in scalable bioprocess solutions for the production of biologics—including recombinant proteins, vaccines, monoclonal antibodies, and blood-derived products—serving both human and animal health sectors. The company is recognized for supporting process development, scale-up to production (up to 2000L cell culture), equipment supply, consulting, and technical support for LATAM biopharma clients. It does not have its own clinical pipeline.

Therapeutic areas: Other
Modalities: Recombinant proteinVaccineMonoclonal antibodyBlood-derived product
Industry: Contract Manufacturing Organization

Partnerships

Notable as distributor/partner with AdvantaPure for single-use systems/equipment; no major pharma/biotech R&D partnerships identified.

Beyond the preview

Go deeper on Vigenius Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vigenius Biotech.

Explore the full profile